NASDAQ · Biotechnology

Altimmune Inc (ALT)

$1.33 -5.67%
23 Oversold Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$3.19-58.31%

Company profile

Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland.

SectorHealthcare
IndustryBiotechnology
Market cap$375.42M
P/E ratioNone
EPS$-0.76
Beta0.146
Dividend yield0.00%
52-week high$6.44
52-week low$1.60

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for ALT

An email when ALT closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 7:10 AM EST